BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,937,000 | +909.8% | 45,892 | +872.9% | 0.95% | +914.9% |
Q2 2022 | $687,000 | -98.7% | 4,717 | -98.9% | 0.09% | -98.1% |
Q1 2022 | $51,356,000 | -19.6% | 433,124 | -6.5% | 4.95% | -15.6% |
Q4 2021 | $63,860,000 | -1.5% | 463,392 | -0.7% | 5.86% | -9.6% |
Q3 2021 | $64,825,000 | +19.6% | 466,668 | -16.4% | 6.49% | +17.4% |
Q2 2021 | $54,198,000 | +41.2% | 558,286 | -0.6% | 5.52% | +23.9% |
Q1 2021 | $38,375,000 | -20.0% | 561,442 | +0.4% | 4.46% | -24.5% |
Q4 2020 | $47,949,000 | +31.8% | 559,437 | -0.0% | 5.90% | +3.2% |
Q3 2020 | $36,378,000 | -17.8% | 559,574 | -7.5% | 5.72% | -31.3% |
Q2 2020 | $44,249,000 | +115.6% | 605,242 | +0.4% | 8.33% | +68.1% |
Q1 2020 | $20,521,000 | -35.6% | 603,036 | +3.0% | 4.95% | -7.5% |
Q4 2019 | $31,863,000 | +33.8% | 585,289 | +2.5% | 5.36% | +25.2% |
Q3 2019 | $23,814,000 | -0.1% | 570,808 | +4.9% | 4.28% | +6.8% |
Q2 2019 | $23,832,000 | -0.2% | 544,223 | +17.3% | 4.01% | -7.4% |
Q1 2019 | $23,889,000 | +60.2% | 464,127 | +15.1% | 4.32% | +37.0% |
Q4 2018 | $14,913,000 | -4.4% | 403,271 | -3.0% | 3.16% | +30.6% |
Q3 2018 | $15,604,000 | +1.3% | 415,555 | +6.6% | 2.42% | -1.7% |
Q2 2018 | $15,408,000 | +129.8% | 389,889 | +49.8% | 2.46% | +199.5% |
Q1 2018 | $6,704,000 | +133.8% | 260,255 | +144.8% | 0.82% | +136.6% |
Q4 2017 | $2,868,000 | – | 106,312 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |